Alcohol Publishes Year-End Special Issue on Fetal Alcohol Spectrum Disorders
Special Issue Presents New Perspectives on Diagnosis and Intervention
New York, NY, December 13, 2010 – Elsevier Inc., the world's leading publisher of scientific, technical and medical information, announced today that Alcohol has published a special year-end double issue on Fetal Alcohol Spectrum Disorders (FASD). It fills an urgent need to bring the widest possible readership current perspectives on using new research methods to improve identification and diagnosis of offspring at risk for FASD and its associated brain damage and behavioral dysfunction.
Journal Editor-in-Chief Charles R. Goodlett said, “It has been nearly four decades since Kenneth Lyons Jones and David Smith published their landmark papers reporting their observation of a constellation of identifiable birth defects in infants of women who drank alcohol heavily during pregnancy. One might expect that, over several decades, some consensus about the basic elements of this neurodevelopmental disorder would have emerged, including the diagnostic features, the core cognitive and behavioral problems, and likely mechanisms of and potential interventions for abnormal brain development. In reality, there are more questions than answers …”
The Special Issue on Fetal Alcohol Spectrum Disorders (FASD) features 15 articles covering emerging research on topics such as: new ways to identify pregnancies at risk for FASD using existing maternal self-report tools; the development of biomarker methods to help improve early identification and diagnosis of at-risk exposure to alcohol; the use of animal models to develop new diagnostic and intervention strategies; and a new framework to improve outcomes for children affected by prenatal alcohol-induced brain damage.
Also included will be three articles from the Collaborative Initiative on Fetal Alcohol Spectrum Disorders (CIFASD), a consortium of international researchers currently in the process of collecting the largest set of integrated clinical data on FASD ever compiled.
The online edition of Alcohol may be viewed via ScienceDirect and via Alcohol’s web site. The latter site includes two, free, selected articles namely “Fetal alcohol spectrum disorders: new perspectives on diagnosis and intervention” and “Effects of moderate drinking during pregnancy on placental gene expression.”
Charles R. Goodlett, Ph.D., is a professor in the Department of Psychology at Indiana University-Purdue University Indianapolis. His research focuses on the biopsychology of addiction and the damaging effects of alcohol on the developing brain.
# # #
Alcohol (http://www.alcoholjournal.org/) is an international, peer-reviewed journal that is devoted to publishing multidisciplinary biomedical research on all aspects of the actions or effects of alcohol on the nervous system and other organs. Published eight times a year, the journal is dedicated to excellence and in-depth reporting of the growing literature on alcoholism as a disease. Topics include, but are not limited to, biomedical factors in the etiology of alcoholism; biomedical factors in the pathologic effects of uncontrolled drinking; biological and biochemical markers in the identification of alcoholism; new drugs and chemotherapeutic strategies in the treatment of uncontrolled drinking; alcohol withdrawal; and psychological and biological problems associated with fetal alcohol syndrome.
Elsevier is a world-leading provider of information solutions that enhance the performance of science, health, and technology professionals, empowering them to make better decisions, deliver better care, and sometimes make groundbreaking discoveries that advance the boundaries of knowledge and human progress. Elsevier provides web-based, digital solutions — among them ScienceDirect, Scopus, Elsevier Research Intelligence, and ClinicalKey — and publishes nearly 2,200 journals, including The Lancet and Cell, and over 25,000 book titles, including a number of iconic reference works.
The company is part of Reed Elsevier Group PLC, a world leading provider of professional information solutions in the Science, Medical, Legal and Risk and Business sectors, which is jointly owned by Reed Elsevier PLC and Reed Elsevier NV. The ticker symbols are REN (Euronext Amsterdam), REL (London Stock Exchange), RUK and ENL (New York Stock Exchange).
Christopher J. Pfister